Search results
Utah NHL Team Files Trademarks for Mammoth, Ice, Yetis, More Possible Nicknames
Bleacher Report· 6 days agoAs the NHL prepares for the Arizona Coyotes' relocation to Utah for the 2024-25 season, the...
Is Ozempic the New Anti-Inflammatory Wonder Drug?
Time Magazine· 2 hours agoThe file included descriptions of her initial diagnosis of Crohn’s disease as a teenager, the multiple operations she had endured to remove diseased...
Marker Therapeutics stock gets Buy from Ladenburg citing CAR-T therapy potential By Investing.com
Investing.com· 2 hours agoOn Tuesday, Marker Therapeutics (NASDAQ:MRKR) stock received a Buy rating from Ladenburg Thalmann,...
Eurozone Bond Yields Trade Flat Ahead of Inflation Data
The Wall Street Journal· 7 hours agoEurozone government bond yields were largely unchanged ahead of flash estimate eurozone inflation...
Foresee Pharmaceuticals Announces First Subject Dosed in its First-in-Human Clinical Trial of FP-020
WJTV Jackson· 5 hours agoForesee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia. The Phase 1 clinical trial is a ...
Philips Posts Record Surge After US Sleep Apnea Settlement
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Royal Philips NV shares soared by a record after a lower-than-expected settlement on...
Alphabet shares target raised on AI-driven growth
Investing.com· 4 days agoBofA Securities has increased its price target on Alphabet Inc (NASDAQ: GOOGL ) shares to $200 from $173, while keeping a Buy rating on the stock. The...
Alphabet's Stock Jumps After Google Parent Reports Earnings, Declares Dividend
The Wall Street Journal· 5 days agoShares of Alphabet are surging after the parent company of Google released its quarterly results and...
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Pharmaceutical Technology via Yahoo Finance· 22 hours agoThis has led to the initiation of the Phase III RESOLUTE clinical trial, which has recruited more...
Bitterroot Bio kickstarts Phase I trial for cardiovascular disease candidate
Clinical Trials Arena via Yahoo Finance· 21 hours agoThe Phase I trial, being conducted in Brisbane, Australia, will evaluate the safety and tolerability...